Journal article
Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life
- Abstract:
-
Nonalcoholic steatohepatitis (NASH) is a prevalent chronic disease that is associated with a spectrum of liver fibrosis and can lead to cirrhosis. Patients with NASH report lower health-related quality of life (HRQoL) than the general population. It remains uncertain how changes in histologic severity are associated with changes in HRQoL. This is a secondary analysis of the Farnesoid X Receptor Ligand Obeticholic Acid in NASH Treatment (FLINT) and Pioglitazone, Vitamin E, or Placebo for Nonal...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 645.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/hep4.2044
Authors
Bibliographic Details
- Publisher:
- Wiley
- Journal:
- Hepatology Communications More from this journal
- Volume:
- 6
- Issue:
- 10
- Pages:
- 2623-2633
- Publication date:
- 2022-07-28
- Acceptance date:
- 2022-06-27
- DOI:
- EISSN:
-
2471-254X
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1266540
- Local pid:
-
pubs:1266540
- Deposit date:
-
2022-07-04
Terms of use
- Copyright holder:
- Heath et al.
- Copyright date:
- 2022
- Rights statement:
- © 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record